KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Non-Current Deferred Tax Liability (2018 - 2023)

Vir Biotechnology (VIR) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $3.3 million as the latest value for Q1 2023.

  • Quarterly Non-Current Deferred Tax Liability fell 82.36% to $3.3 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Mar 2023, down 82.36% year-over-year, with the annual reading at $3.3 million for FY2022, 82.36% down from the prior year.
  • Non-Current Deferred Tax Liability hit $3.3 million in Q1 2023 for Vir Biotechnology, roughly flat from $3.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $18.4 million in Q4 2021 to a low of $3.3 million in Q4 2020.
  • Historically, Non-Current Deferred Tax Liability has averaged $7.3 million across 5 years, with a median of $3.3 million in 2019.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 466.83% in 2021 and later tumbled 82.36% in 2022.
  • Year by year, Non-Current Deferred Tax Liability stood at $3.3 million in 2019, then decreased by 1.57% to $3.3 million in 2020, then surged by 466.83% to $18.4 million in 2021, then crashed by 82.36% to $3.3 million in 2022, then changed by 0.0% to $3.3 million in 2023.
  • Business Quant data shows Non-Current Deferred Tax Liability for VIR at $3.3 million in Q1 2023, $3.3 million in Q4 2022, and $18.4 million in Q3 2022.